跳至主要内容
临床试验/NCT06763185
NCT06763185已完成不适用

Comparative Effects of Conventional Cow's Milk Versus Milk Free of A1-type Beta-casein on Gastrointestinal Physiology and Symptoms of Digestive Discomfort in Participants Intolerant to Conventional Cow's Milk: a Randomised Controlled Trial

a2 Milk Company Ltd.2 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2017年4月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
2
主要终点
Severity of bloating, abdominal pain, gas, borborygmus, eructation, and diarrhoea measured via Visual Analogue Scale (VAS)

研究概览

简要总结

This was a single-site, double-blind, randomised, controlled, crossover study, which aimed to compare the effects of conventional cow's milk (CON, containing both A1- and A2-types of beta-casein) versus milk free of A1-type beta-casein (A1PF milk) on gastrointestinal (GI) physiology and symptoms of digestive discomfort in non-regular milk drinkers with self-reported intolerance to conventional cow's milk. The study location was the Pennington Biomedical Research Center in Louisiana, USA. The study comprised a 2-week washout period, 2 weeks of milk consumption, crossover, a second 2-week washout period, and a second 2-week period of milk consumption. Eligible participants were stratified by sex to achieve an approximate 1:1 male to female ratio and were randomised to receive conventional cow's milk (sequence 1) or A1PF milk (sequence 2) during the first period of milk consumption. During the second period of milk consumption, participant groups underwent crossover to receive the alternate study milk.

Milk was consumed three times per day after meals, with 250 mL provided at each administration. During washout periods, participants were required to avoid all dairy products and use only rice milk to replace any normal dairy intake, and to avoid foods with very high fermentable oligosaccharides, disaccharides, monosaccharides, and polyols content, to avoid potential confounding of the symptoms experienced. Any medication, nutritional supplements, dairy products, acidophilus milk, or probiotics were prohibited during the study.

The study protocol and all related documentation were approved by the Pennington Biomedical Research Center Institution Review Board. The study was conducted in accordance with the principles of the Declaration of Helsinki and the Good Clinical Practice Guidelines of the International Conference on Harmonisation. All participants provided written informed consent prior to initiating any study procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 68 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female participants aged 18 to 68 years
  • Irregularly consumed milk
  • Had self-reported mild-to-moderate digestive discomfort after milk consumption
  • Had normal electrocardiograms and blood pressure during quiet respiration

排除标准

  • Known allergies to dairy products
  • Severe milk intolerance
  • A history of faecal impaction
  • Having suffered from GI disorders (e.g., irritable bowel syndrome, colitis, ulcerative colitis, or coeliac disease)
  • Currently being administered drugs for cardiovascular or metabolic disease
  • Trying to lose weight by following a diet or exercise regimen
  • Took any appetite or weight loss drugs for the previous three months

结局指标

主要结局

Severity of bloating, abdominal pain, gas, borborygmus, eructation, and diarrhoea measured via Visual Analogue Scale (VAS)

时间窗: At day 28 and day 56 (day 1 is study start)

VAS: 0 = never; 1 = rarely; 2 = frequently; 3 = all the time

次要结局

未报告次要终点

研究者

发起方
a2 Milk Company Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验